Annual ROE:
-62.49%-4.15%(-7.11%)Summary
- As of today (October 4, 2025), ADPT annual return on equity is -62.49%, with the most recent change of -4.15% (-7.11%) on December 31, 2024.
- During the last 3 years, ADPT annual ROE has fallen by -31.72% (-103.09%).
- ADPT annual ROE is now -428.72% below its all-time high of 19.01%, reached on December 31, 2017.
Performance
ADPT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-58.44%+4.21%(+6.72%)Summary
- As of today (October 4, 2025), ADPT quarterly return on equity is -58.44%, with the most recent change of +4.21% (+6.72%) on June 30, 2025.
- Over the past year, ADPT quarterly ROE has increased by +9.06% (+13.42%).
- ADPT quarterly ROE is now -554.08% below its all-time high of 12.87%, reached on June 30, 2019.
Performance
ADPT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ADPT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -7.1% | +13.4% |
| 3Y3 Years | -103.1% | -52.0% |
| 5Y5 Years | -40.5% | -129.5% |
ADPT ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -103.1% | at low | -53.3% | +15.7% |
| 5Y | 5-Year | -180.8% | at low | -188.0% | +15.7% |
| All-Time | All-Time | -428.7% | at low | -554.1% | +91.1% |
ADPT ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -58.44%(-6.7%) |
| Mar 2025 | - | -62.65%(-1.8%) |
| Dec 2024 | -62.49%(+7.1%) | -63.81%(-7.9%) |
| Sep 2024 | - | -69.29%(+2.7%) |
| Jun 2024 | - | -67.50%(+10.7%) |
| Mar 2024 | - | -60.96%(+5.7%) |
| Dec 2023 | -58.34%(+55.5%) | -57.65%(+25.5%) |
| Sep 2023 | - | -45.94%(+10.2%) |
| Jun 2023 | - | -41.70%(+4.5%) |
| Mar 2023 | - | -39.89%(+4.6%) |
| Dec 2022 | -37.52%(+21.9%) | -38.13%(-3.1%) |
| Sep 2022 | - | -39.35%(+2.4%) |
| Jun 2022 | - | -38.44%(+8.2%) |
| Mar 2022 | - | -35.54%(+17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -30.77%(+38.3%) | -30.33%(+14.3%) |
| Sep 2021 | - | -26.54%(+7.5%) |
| Jun 2021 | - | -24.69%(+5.6%) |
| Mar 2021 | - | -23.37%(+1.3%) |
| Dec 2020 | -22.25%(-50.0%) | -23.06%(+13.7%) |
| Sep 2020 | - | -20.29%(-20.3%) |
| Jun 2020 | - | -25.46%(-28.8%) |
| Mar 2020 | - | -35.78%(-23.0%) |
| Dec 2019 | -44.46%(-347.6%) | -46.45%(-92.9%) |
| Sep 2019 | - | -655.48%(-5193.1%) |
| Jun 2019 | - | 12.87%(+83.6%) |
| Mar 2019 | - | 7.01%(+46.0%) |
| Dec 2018 | 17.96%(-5.5%) | 4.80% |
| Dec 2017 | 19.01% | - |
FAQ
- What is Adaptive Biotechnologies Corporation annual return on equity?
- What is the all-time high annual ROE for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation annual ROE year-on-year change?
- What is Adaptive Biotechnologies Corporation quarterly return on equity?
- What is the all-time high quarterly ROE for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation quarterly ROE year-on-year change?
What is Adaptive Biotechnologies Corporation annual return on equity?
The current annual ROE of ADPT is -62.49%
What is the all-time high annual ROE for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high annual return on equity is 19.01%
What is Adaptive Biotechnologies Corporation annual ROE year-on-year change?
Over the past year, ADPT annual return on equity has changed by -4.15% (-7.11%)
What is Adaptive Biotechnologies Corporation quarterly return on equity?
The current quarterly ROE of ADPT is -58.44%
What is the all-time high quarterly ROE for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high quarterly return on equity is 12.87%
What is Adaptive Biotechnologies Corporation quarterly ROE year-on-year change?
Over the past year, ADPT quarterly return on equity has changed by +9.06% (+13.42%)